ASPG and acute lymphoblastic leukemia: The first model of industry-academia partnership set the platform for the development of three drugs, namely diselenodipropionic acid (DSePA), chlorophyllin, and novel asparaginase mutants for the treatment of acute lymphoblastic leukaemia (ALL).